GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IXICO PLC (LSE:IXI) » Definitions » Sale Of Investment

IXICO (LSE:IXI) Sale Of Investment : £0.00 Mil (TTM As of Sep. 2023)


View and export this data going back to 1996. Start your Free Trial

What is IXICO Sale Of Investment?

IXICO's sale of investment for the six months ended in Sep. 2023 was £0.00 Mil. It means IXICO gained £0.00 Mil from selling investments. IXICO's sale of investment for the trailing twelve months (TTM) ended in Sep. 2023 was £0.00 Mil.

Compared with last quarter (£0.00 Mil in Mar. 2023 ), IXICO gained the same money from selling investments in Sep. 2023 (£0.00 Mil).

IXICO Sale Of Investment Historical Data

The historical data trend for IXICO's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IXICO Sale Of Investment Chart

IXICO Annual Data
Trend Sep13 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

IXICO Semi-Annual Data
Sep13 Mar14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

IXICO Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IXICO Sale Of Investment Related Terms

Thank you for viewing the detailed overview of IXICO's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

IXICO (LSE:IXI) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IXICO PLC (LSE:IXI) » Definitions » Sale Of Investment
Comparable Companies
LSE:FAB LSE:GENF LSE:OCTP LSE:VAL AQSE:INC LSE:APTA LSE:EVG LSE:RENE LSE:PYC LSE:BSFA OCSE:NOVO B VRTX REGN ASX:CSL XKRX:207940 MRNA XKRX:068270 XBRU:ARGX XBRU:UCB BNTX
Traded in Other Exchanges
PHYOF:USA
Address
15 Long Lane, 4th Floor, Griffin Court, London, GBR, EC1A 9PN
Website
https://www.ixico.com
IXICO PLC is a UK-based company engaged in providing clinical trial services and technology to evaluate imaging endpoints to pharmaceutical companies. Its therapeutic areas include Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis, Progressive Supranuclear Palsy, and Other Rare Neurological Diseases. Services offered by the company are Early Phase Clinical Development, Late Phase Clinical Development, Post-Marketing, and Consultancy. The company's geographical segments include the United States, Switzerland, the United Kingdom, the Netherlands, Ireland and other- Europe. The Company work with healthcare organizations across the entire clinical research journey, for drug development analytics, medical imaging operations and post-marketing surveillance.

IXICO (LSE:IXI) Headlines

No Headlines